A carregar...
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
BACKGROUND: Prostate-specific antigen (PSA) testing has limited accuracy for the early detection of prostate cancer (PCa). OBJECTIVE: To assess the value added by percentage of free to total PSA (%fPSA), prostate cancer antigen 3 (PCA3), and a kallikrein panel (4k-panel) to the European Randomised S...
Na minha lista:
| Publicado no: | Eur Urol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407822/ https://ncbi.nlm.nih.gov/pubmed/25168616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.08.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|